» Articles » PMID: 24165983

Socially-integrated Transdisciplinary HIV Prevention

Abstract

Current ideas about HIV prevention include a mixture of primarily biomedical interventions, socio-mechanical interventions such as sterile syringe and condom distribution, and behavioral interventions. This article presents a framework for socially-integrated transdisciplinary HIV prevention that may improve current prevention efforts. It first describes one socially-integrated transdisciplinary intervention project, the Transmission Reduction Intervention Project. We focus on how social aspects of the intervention integrate its component parts across disciplines and processes at different levels of analysis. We then present socially-integrated perspectives about how to improve combination antiretroviral treatment (cART) processes at the population level in order to solve the problems of the treatment cascade and make "treatment as prevention" more effective. Finally, we discuss some remaining problems and issues in such a social transdisciplinary intervention in the hope that other researchers and public health agents will develop additional socially-integrated interventions for HIV and other diseases.

Citing Articles

Changes in Stigma and Social Support among Participants in a Randomized Trial of a Novel Expanded Social Network-based HIV Testing Intervention in KwaZulu-Natal, South Africa.

Williams L, van Heerden A, Friedman S, Chibi B, Rodriguez W, Memela P AIDS Behav. 2024; 28(8):2619-2629.

PMID: 38833064 DOI: 10.1007/s10461-024-04379-y.


Estimating Causal Effects of HIV Prevention Interventions with Interference in Network-based Studies among People Who Inject Drugs.

Lee T, Buchanan A, Katenka N, Forastiere L, Halloran M, Friedman S Ann Appl Stat. 2024; 17(3):2165-2191.

PMID: 38250709 PMC: 10798667. DOI: 10.1214/22-aoas1713.


Busting the myth: waste-to-energy plants and public health.

Traven L Arh Hig Rada Toksikol. 2023; 74(2):142-143.

PMID: 37357880 PMC: 10291493. DOI: 10.2478/aiht-2023-74-3733.


Integration of a geospatially targeted community-based testing approach with respondent-driven sampling to identify people who inject drugs living with HIV and HCV in Patti and Gorakhpur, India.

Loeb T, McFall A, Srikrishnan A, Anand S, Vasudevan C, Mehta S Drug Alcohol Depend. 2023; 247:109874.

PMID: 37087926 PMC: 10612114. DOI: 10.1016/j.drugalcdep.2023.109874.


Methods for Assessing Spillover in Network-Based Studies of HIV/AIDS Prevention among People Who Use Drugs.

Buchanan A, Katenka N, Lee Y, Wu J, Pantavou K, Friedman S Pathogens. 2023; 12(2).

PMID: 36839598 PMC: 9967280. DOI: 10.3390/pathogens12020326.


References
1.
Friedman S, Neaigus A, Jose B, Curtis R, Goldstein M, Ildefonso G . Sociometric risk networks and risk for HIV infection. Am J Public Health. 1997; 87(8):1289-96. PMC: 1381088. DOI: 10.2105/ajph.87.8.1289. View

2.
Sypsa V, Paraskevis D, Malliori M, Nikolopoulos G, Panopoulos A, Kantzanou M . Homelessness and Other Risk Factors for HIV Infection in the Current Outbreak Among Injection Drug Users in Athens, Greece. Am J Public Health. 2014; 105(1):196-204. PMC: 4145040. DOI: 10.2105/AJPH.2013.301656. View

3.
Friedman S, Maslow C, Bolyard M, Sandoval M, Mateu-Gelabert P, Neaigus A . Urging others to be healthy: "intravention" by injection drug users as a community prevention goal. AIDS Educ Prev. 2004; 16(3):250-63. DOI: 10.1521/aeap.16.3.250.35439. View

4.
Grierson J, Koelmeyer R, Smith A, Pitts M . Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians. HIV Med. 2011; 12(9):562-9. DOI: 10.1111/j.1468-1293.2011.00928.x. View

5.
Duong Y, Qiu M, DE A, Jackson K, Dobbs T, Kim A . Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies. PLoS One. 2012; 7(3):e33328. PMC: 3314002. DOI: 10.1371/journal.pone.0033328. View